The reovirus variant RP116 is oncolytic in immunocompetent models and generates reduced neutralizing antibodies to Type 3 Dearing.
Song KH, Xiang X, Lee SH, Woo JK, Enkhtaivan G, Giraldo CR, Lee YR, Jeong YJ, Pashangzadeh S, Sharifi N, Yang AD, Hoang HD, Cho NH, Lee YS, Park DG, Alain T.
Song KH, et al. Among authors: lee sh, lee yr, lee ys.
Mol Ther Oncol. 2024 Jun 29;32(3):200846. doi: 10.1016/j.omton.2024.200846. eCollection 2024 Sep 19.
Mol Ther Oncol. 2024.
PMID: 39354956
Free PMC article.